Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2019-04-22 10:40 Tx date 2019-04-17 |
$CMTA
Clementia Pharmaceuticals Inc. |
Legault, Pierre
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
59 - Exercise for cash
|
$-280,800
-11,232 vol $25.00 each |
0 | |
Filed 2019-04-22 10:39 Tx date 2019-04-17 |
$CMTA
Clementia Pharmaceuticals Inc. |
Legault, Pierre
4 - Director of Issuer
Direct Ownership
|
Options
59 - Exercise for cash
|
-35,970 vol |
0 | |
Filed 2019-03-01 Tx date 2019-02-24 |
$CMTA
Clementia Pharmaceuticals Inc. |
Legault, Pierre
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
56 - Grant of rights
|
+7,845 vol |
11,232 | |
Filed 2019-01-04 Tx date 2018-12-31 |
$CMTA
Clementia Pharmaceuticals Inc. |
Legault, Pierre
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
56 - Grant of rights
|
+1,142 vol |
3,387 | |
Filed 2018-11-29 Tx date 2018-11-06 |
$CMTA
Clementia Pharmaceuticals Inc. |
Legault, Pierre
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+11,990 vol |
35,970 | |
Filed 2018-11-29 Tx date 2018-11-06 |
$CMTA
Clementia Pharmaceuticals Inc. |
Legault, Pierre
4 - Director of Issuer
Direct Ownership
|
Options
56 - Grant of rights
|
+11,990 vol |
||
Filed 2018-10-04 Tx date 2018-09-30 |
$CMTA
Clementia Pharmaceuticals Inc. |
Legault, Pierre
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
56 - Grant of rights
|
+1,205 vol |
2,245 | |
Filed 2018-07-04 Tx date 2018-06-30 |
$CMTA
Clementia Pharmaceuticals Inc. |
Legault, Pierre
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
56 - Grant of rights
|
+807 vol |
1,040 | |
Filed 2018-04-17 Tx date 2018-03-31 |
$CMTA
Clementia Pharmaceuticals Inc. |
Legault, Pierre
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
56 - Grant of rights
|
+233 vol |
233 | |
Filed 2018-04-17 Tx date 2018-03-31 |
$CMTA
Clementia Pharmaceuticals Inc. |
Legault, Pierre
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
56 - Grant of rights
|
+233 vol |
||
Filed 2018-04-17 Tx date 2018-03-31 |
$CMTA
Clementia Pharmaceuticals Inc. |
Legault, Pierre
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
56 - Grant of rights
|
+233 vol |
||
Filed 2018-04-17 Tx date 2018-01-31 |
$CMTA
Clementia Pharmaceuticals Inc. |
Legault, Pierre
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-04-17 Tx date 2018-01-31 |
$CMTA
Clementia Pharmaceuticals Inc. |
Legault, Pierre
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-04-17 Tx date 2018-01-31 |
$CMTA
Clementia Pharmaceuticals Inc. |
Legault, Pierre
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-04-16 Tx date 2018-03-31 |
$CMTA
Clementia Pharmaceuticals Inc. |
Legault, Pierre
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
56 - Grant of rights
|
+233 vol |
233 | |
Filed 2018-04-16 Tx date 2018-01-31 |
$CMTA
Clementia Pharmaceuticals Inc. |
Legault, Pierre
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-03-05 Tx date 2018-02-27 |
$CMTA
Clementia Pharmaceuticals Inc. |
Legault, Pierre
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$330,924
+23,980 vol $13.80 each |
||
Filed 2018-03-05 Tx date 2018-02-27 |
$CMTA
Clementia Pharmaceuticals Inc. |
Legault, Pierre
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$330,924
+23,980 vol $13.80 each |
23,980 | |
Filed 2018-03-02 Tx date 2018-01-31 |
$CMTA
Clementia Pharmaceuticals Inc. |
Legault, Pierre
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-03-02 Tx date 2018-02-27 |
$CMTA
Clementia Pharmaceuticals Inc. |
Legault, Pierre
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$330,924
+23,980 vol $13.80 each |
23,980 |